Clinical trial
fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia
NCT01046526
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedfMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Psychopathologyunresolved
Interventions
Sponsors & collaborators
National Institute on Drug Abuse (NIDA)lead sponsor
National Institute of Mental Health (NIMH)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01046526 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.